Healthcare provider profile · identity verified

Andy H. Vila, MD

Family Practice · ELK GROVE, CA · NPI 1639257363

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	693	232
Losartan Potassium	Losartan Potassium	395	143
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	331	75
Amlodipine Besylate	Amlodipine Besylate	316	117
Fluticasone Propionate	Fluticasone Propionate	288	109
Lisinopril	Lisinopril	246	90
Levothyroxine Sodium	Levothyroxine Sodium	227	72
Pantoprazole Sodium	Pantoprazole Sodium	212	80
Famotidine	Famotidine	202	72
Metoprolol Tartrate	Metoprolol Tartrate	197	64
Gabapentin	Gabapentin	179	63
Albuterol Sulfate Hfa	Albuterol Sulfate	174	90
Tamsulosin Hcl	Tamsulosin Hcl	161	58
Metformin Hcl Er	Metformin Hcl	152	59
Trazodone Hcl	Trazodone Hcl	141	48
Hydrochlorothiazide	Hydrochlorothiazide	126	47
Furosemide	Furosemide	117	50
Simvastatin	Simvastatin	111	37
Omeprazole	Omeprazole	108	45
Alvesco	Ciclesonide	104	43
Meloxicam	Meloxicam	104	34
Ibuprofen	Ibuprofen	99	40
Prednisone	Prednisone	99	56
Glipizide	Glipizide	96	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	28
Sertraline Hcl	Sertraline Hcl	84	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	82	20
Finasteride	Finasteride	79	28
Metoprolol Succinate	Metoprolol Succinate	79	30
Rosuvastatin Calcium	Rosuvastatin Calcium	76	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	25
Lorazepam	Lorazepam	73	30
Breyna	Budesonide/Formoterol Fumarate	71	24
Azelastine Hcl	Azelastine Hcl	69	26
Ozempic	Semaglutide	69	13
Metformin Hcl	Metformin Hcl	66	25
Atenolol	Atenolol	65	21
Baclofen	Baclofen	61	24
Terazosin Hcl	Terazosin Hcl	60	21
Clopidogrel	Clopidogrel Bisulfate	59	19
Fluocinonide	Fluocinonide	55	30
Allopurinol	Allopurinol	53	22
Pradaxa	Dabigatran Etexilate Mesylate	51	19
Doxycycline Monohydrate	Doxycycline Monohydrate	49	45
Lovastatin	Lovastatin	49	15
Hydralazine Hcl	Hydralazine Hcl	48	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	42
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Alprazolam	Alprazolam	46	suppressed
Alendronate Sodium	Alendronate Sodium	41	19
Escitalopram Oxalate	Escitalopram Oxalate	41	18
Hydrocortisone	Hydrocortisone	41	26
Triamcinolone Acetonide	Triamcinolone Acetonide	40	29
Fluoxetine Hcl	Fluoxetine Hcl	39	16
Potassium Chloride	Potassium Chloride	38	14
Wixela Inhub	Fluticasone Propion/Salmeterol	38	21
Spiriva Respimat	Tiotropium Bromide	37	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	35	35
Pravastatin Sodium	Pravastatin Sodium	35	11
Temazepam	Temazepam	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	32	27
Montelukast Sodium	Montelukast Sodium	32	12
Jardiance	Empagliflozin	31	11
Tramadol Hcl	Tramadol Hcl	31	suppressed
Carvedilol	Carvedilol	30	12
Ciclopirox	Ciclopirox	29	11
Humulin N	Insulin Nph Human Isophane	29	12
Tizanidine Hcl	Tizanidine Hcl	28	13
Cefadroxil	Cefadroxil	27	26
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	27	11
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	26	11
Warfarin Sodium	Warfarin Sodium	26	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	12
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Mupirocin	Mupirocin	23	11
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Eliquis	Apixaban	22	suppressed
Nabumetone	Nabumetone	22	14
Acyclovir	Acyclovir	21	11
Amoxicillin	Amoxicillin	21	14
Glipizide Er	Glipizide	21	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	18
Ezetimibe	Ezetimibe	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Liraglutide	Liraglutide	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Humulin R	Insulin Regular, Human	18	suppressed
Victoza 2-Pak	Liraglutide	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Cephalexin	Cephalexin	16	16
Nitroglycerin	Nitroglycerin	16	suppressed
Nystatin	Nystatin	16	13
Propranolol Hcl	Propranolol Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Tadalafil	Tadalafil	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Metronidazole	Metronidazole	15	13
Spironolactone	Spironolactone	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Digoxin	Digoxin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Fluconazole	Fluconazole	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	11
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error